MDS
Showing NaN - NaN of 12
Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (Orca-T,
Recruiting
- Acute Myeloid Leukemia
- +7 more
- Orca-T
- Standard-of-Care
-
Duarte, California
- +13 more
Jan 25, 2023
Acute Leukemia, MDS Trial in Chicago (device, drug, other)
Recruiting
- Acute Leukemia
- MDS
- Arm1
- Arm 1
-
Chicago, IllinoisUniversity of Illinois Cancer Center
Oct 13, 2022
Myelodysplastic Syndrome, MDS, Refractory Anemia With Excess Blasts Trial in Worldwide (rigosertib, Any approved or
Terminated
- Myelodysplastic Syndrome
- +3 more
- rigosertib
- +2 more
-
La Jolla, California
- +157 more
Sep 22, 2022
Hematologic Malignancy, AML, ALL Trial in Australia, United States (Tagraxofusp, Fludarabine, Cytarabine)
Not yet recruiting
- Hematologic Malignancy
- +10 more
- Tagraxofusp
- +8 more
-
Los Angeles, California
- +28 more
Jul 26, 2022
Relapsed/Refractory AML, AML, Adult, MDS Trial in United States (NKX101 - CAR NK cell therapy)
Recruiting
- Relapsed/Refractory AML
- +3 more
- NKX101 - CAR NK cell therapy
-
Denver, Colorado
- +6 more
Apr 8, 2022
Myelodysplastic Syndrome, MDS Trial in Canada, United States (ASTX727 Dose Escalation, ASTX727 Dose Confirmation, ASTX727
Completed
- Myelodysplastic Syndrome
- MDS
- ASTX727 Dose Escalation
- +2 more
-
Phoenix, Arizona
- +16 more
Dec 1, 2020
MDS Trial in Chicago (Lenalidomide and azacitidine combination)
Terminated
- MDS
- Lenalidomide and azacitidine combination
-
Chicago, IllinoisRush University Medical Center
Nov 2, 2020
MDS, MDS, RAEB Trial in Worldwide (ON 01910.Na)
Completed
- Myelodysplastic Syndromes
- +3 more
- ON 01910.Na
-
Scottsdale, Arizona
- +86 more
Jun 29, 2020
Leukemia, Lymphoma, MDS Trial in Chicago (Conditioning Regimen & GVHD Prophylaxis)
Withdrawn
- Leukemia
- +2 more
- Conditioning Regimen & GVHD Prophylaxis
-
Chicago, IllinoisAnn & Robert H. Lurie Children's Hospital of Chicago
Aug 28, 2019
AML, ALL, Blast Crisis Trial in United States (TG02 citrate, Carfilzomib, Dexamethasone)
Completed
- AML
- +4 more
- TG02 citrate
- +2 more
-
Denver, Colorado
- +8 more
May 5, 2016